Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Curr Cancer Drug Targets. 2016;16(6):489–508. doi: 10.2174/1568009616666151130214646

Fig. (2).

Fig. (2).

Examples of tumor vasculature targeting peptides. (a) A Peptide-C based therapeutic that targets melanoma and inhibits angiogenesis through the conjugated anti-angiogenic peptide. (b) A shortened peptide mimic of a larger SPARC peptide that has tumor-homing properties. (c) LyP-1, a peptide that can be utilized to target a tumor’s lymphatic vasculature. (d) iRGD, a tumor penetrating peptide.